Patents by Inventor Frank BRUCHERTSEIFER

Frank BRUCHERTSEIFER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of PMSA expressing cancers
    Patent number: 10980901
    Abstract: The invention relates to a method for treating PSMA expressing cancers, wherein the method comprises administering to patient in need thereof an effective amount of one or more Ac-225-radiopharmaceuticals, wherein the effective amount of said one or more Ac-225-radiopharmaceuticals is administered as a dosage of from 25 kBq to 400 kBq/kg of body weight of said patient or wherein the effective amount of said one or more Ac-225-radiopharmaceuticals is administered as a unitary dosage of from 3 MBq to 30 MBq to said patient.
    Type: Grant
    Filed: December 15, 2016
    Date of Patent: April 20, 2021
    Assignees: The European Atomic Energy Community (EURATOM), Represented by the European Commission, Universität Heidelberg
    Inventors: Alfred Morgenstern, Frank Bruchertseifer, Christos Apostolidis, Uwe Haberkorn, Frederik Giesel, Clemens Kratochwil
  • TREATMENT OF PMSA EXPRESSING CANCERS
    Publication number: 20200016281
    Abstract: The invention relates to a method for treating PSMA expressing cancers, wherein the method comprises administering to patient in need thereof an effective amount of one or more Ac-225-radiopharmaceuticals, wherein the effective amount of said one or more Ac-225-radiopharmaceuticals is administered as a dosage of from 25 kBq to 400 kBq/kg of body weight of said patient or wherein the effective amount of said one or more Ac-225-radiopharmaceuticals is administered as a unitary dosage of from 3 MBq to 30 MBq to said patient.
    Type: Application
    Filed: December 15, 2016
    Publication date: January 16, 2020
    Inventors: Alfred MORGENSTERN, Frank BRUCHERTSEIFER, Christos APOSTOLIDIS, Uwe HABERKORN, Frederik GIESEL, Clemens KRATOCHWIL
  • SYNTHESIS OF BIOLOGICAL COMPOUNDS LABELED WITH THE ALPHA EMITTER Ac-225
    Publication number: 20150157742
    Abstract: A method is described for producing a radioconjugate labeled with radionuclide Ac-225 comprising the step of chelating said radionuclide Ac-225 with a conjugated chelate compound in a chelation reaction mixture to obtain a radioconjugate labeled with Ac-225, wherein the pH of the chelation reaction mixture is comprised between 7.1 and 10, preferably between 8.0 and 9.5, more preferably about 9.0.
    Type: Application
    Filed: December 11, 2013
    Publication date: June 11, 2015
    Applicant: The European Atomic Energy Community (EURATOM), represented by the European Commission
    Inventors: Alfred MORGENSTERN, Frank BRUCHERTSEIFER, Christos APOSTOLIDIS